Pharma Journalist - Page 52 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Kexing Biopharm Partners with IQVIA to Drive Global Expansion

Viatris Receives FDA Approval for First Generic Iron Sucrose Injection in U.S.

FDA Grants Accelerated Approval to Boehringer’s HERNEXEOS for HER2-Mutant Lung Cancer

FDA Grants Priority Review to Gepotidacin for Oral Treatment of Gonorrhea

Sartorius Stedim Biotech and Nanotein Partner to Boost Cell Therapy Manufacturing

FDA Accepts Arvinas’ NDA for Vepdegestrant in ER+/HER2- Breast Cancer with ESR1 Mutation

Ono and Seikagaku Partner to Co-Develop and Market Gel-One for Osteoarthritis in Japan

CorMedix to Acquire Melinta, Expanding Acute Care Portfolio

Valneva: FDA Lifts Pause on IXCHIQ for Elderly, Updates Prescribing Info

Genmab’s EPCORE FL-1 Trial Meets Goals in R/R FL